Clinatec is a biomedical research center based at the Polygone Scientifique in Grenoble. Doctors, biologists and micro- and nanotechnology experts work side by side at the 6,000 m² facility. Around a hundred researchers and employees work at the center.

During the past decade, CLINATEC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CLINATEC" #1 collaborator was "Commissariat A L'energie Atomique" with 3 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "MEDIMPRINT" with 1 trials as a collaborator, "National Cancer Institute, France" with 1 trials as a collaborator and "Équipe 5 Neuroimagerie et perfusion cérébrale, Grenoble Institut des Neurosciences (GIN)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "CLINATEC" are "Cerebral Primitive Tumor With Chirurgical Indication" (1 trials), "Cluster Headache" (1 trials), "Functional Brain Mapping" (1 trials), "Glioma : Oligodendroglioma or Astrocytoma" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "CLINATEC" in a lesser frequency.

Most popular intervention types in "CLINATEC" are "Device" (9 trials), "Behavioral" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Imaging devices" (2 trials), "32 channels Deep Brain Stimulator" (1 trials), "Brain Tissue Imprint - Medical Device (ProTool)" (1 trials), "Brain-computer interface (BCI) platform including two implanted remotely powered ElectroCorticoGraph (ECoG) recording devices and an exoskeleton" (1 trials) and "C13 N15 Valine" (1 trials). Other intervention names were less common.

The vast majority of trials in "CLINATEC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "CLINATEC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CLINATEC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CLINATEC, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".